Haemonetics (HAE) PT Raised to $77 at Morgan Stanley
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $100.83 -2.26%
Rating Summary:
10 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 13 | New: 29
Rating Summary:
10 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 13 | New: 29
Join SI Premium – FREE
Morgan Stanley raised its price target on Haemonetics (NYSE: HAE) to $77.00 (from $74.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Starts Hanwha Ocean Co Ltd (042660:KS) at Reduce
- Qantas Airways Ltd. (QAN:AU) (QABSY) PT Lowered to AUD11.70 at CLSA
- CTG Duty Free Corp Ltd (601888:CH) PT Lowered to RMB72 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
